World Lifestyler
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
  • Art & Culture
    • Architecture
    • Art & Exhibitions
    • Books
    • Design
    • Film & Music
  • Competitions
    • Dining Experiences
    • Hotel Stays
    • Luxury Experiences
    • Product Giveaways
    • Reader Exclusives
    • Travel Giveaways
  • Food & Drink
    • Chefs
    • Coffee Culture
    • Food Destinations
    • Recipes
    • Restaurants
    • Wine & Spirits
  • Lifestyle
    • Design
    • Fashion
    • Health & Wellbeing
    • Homes & Property
    • Love & Romance
  • People
    • Creatives
    • Entrepreneurs
    • Icons
    • Interviews
    • Profiles
    • Rising Talent
  • Travel
    • Adventure & Experience Travel
    • City Guides
    • Destinations
    • Hotels
    • Secret Spots
    • Travel Trends
No Result
View All Result
WORLD LIFESTYLER
No Result
View All Result
Home Press Releases Press Releases - Lifestyle

NASDAQ: ODD DEADLINE REMINDER: Berger Montague Reminds ODDITY Tech Ltd. (NASDAQ: ODD) Investors of Important Class Action Lawsuit Deadline

Cision PR Newswire by Cision PR Newswire
May 1, 2026
in Press Releases - Lifestyle
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

PHILADELPHIA, May 1, 2026 /PRNewswire/ — National plaintiffs’ law firm Berger Montague PC announces a class action lawsuit against ODDITY Tech Ltd. (NASDAQ: ODD) (“Oddity Tech” or the “Company”) on behalf of investors who purchased or acquired Oddity Tech shares during the period from February 26, 2025 through February 24, 2026 (the “Class Period”).


A national class action and commercial litigation law firm with nationally known attorneys highly sought after for their legal skills. (PRNewsFoto/Berger Montague)

Investor Deadline: Investors who purchased or acquired Oddity Tech securities during the Class Period may, no later than May 11, 2026, seek to be appointed as a lead plaintiff representative of the class. To learn your rights, CLICK HERE.

The Company, headquartered in Tel Aviv, Israel, operates a technology platform that develops and scales consumer beauty and wellness brands through proprietary data science, artificial intelligence, and digital marketing.

According to the suit, on February 25, 2026, Oddity Tech disclosed that it had experienced a “dislocation” with its largest advertising partner caused by algorithm changes that diverted advertising placements to lower quality auctions at abnormally high costs, resulting in significantly increased user acquisition costs. The Company also warned that it expected first quarter 2026 revenue to decline approximately 30% year-over-year.

On this news, Oddity Tech’s Class A ordinary share price fell $14.28 per share, or 49.21%, to close at $14.74 per share on February 25, 2026.

If you are an Oddity Tech investor and would like to learn more about this action, CLICK HERE or please contact Berger Montague: Andrew Abramowitz at aabramowitz@bergermontague.com or (215) 875-3015, or Caitlin Adorni at cadorni@bergermontague.com or (267)764-4865.

About Berger Montague

Berger Montague is one of the nation’s preeminent law firms focusing on complex civil litigation, class actions, and mass torts in federal and state courts throughout the United States. With more than $2.4 billion in 2025 post-trial judgments alone, the Firm is a leader in the fields of complex litigation, antitrust, consumer protection, defective products, environmental law, employment law, securities, and whistleblower cases, among many other practice areas. For over 55 years, Berger Montague has played leading roles in precedent-setting cases and has recovered over $50 billion for its clients and the classes they have represented. Berger Montague is headquartered in Philadelphia and has offices in Chicago; Malvern, PA; Minneapolis; San Diego; San Francisco; Toronto, Canada; Washington, D.C., and Wilmington, DE.

For more information or to discuss your rights, please contact:

Andrew Abramowitz
Berger Montague
(215) 875-3015
aabramowitz@bergermontague.com 

Caitlin Adorni
Berger Montague
(267) 764-4865
cadorni@bergermontague.com  

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nasdaq-odd-deadline-reminder-berger-montague-reminds-oddity-tech-ltd-nasdaq-odd-investors-of-important-class-action-lawsuit-deadline-302759893.html

SOURCE Berger Montague

Cision PR Newswire

Cision PR Newswire

Related Posts

PetMade Formulates Veterinarian-Approved Dog Supplements for Heart Health Featuring CoQ10 and Omega-3s

May 1, 2026

Lumicell Showcases Expanded Scientific and Clinical Engagement at ASBrS 2026 Annual Meeting

May 1, 2026

PJM Board Names David E. Mills as PJM President and CEO

May 1, 2026

BURN Launches BUILD, a New Strength Training Concept

May 1, 2026

Open Networking & Edge Summit Heads to Japan to Advance AI-Native Networking, 6G, and Edge AI Innovation

May 1, 2026

Vendor Neutral Archive (VNA) & PACS Market worth $8.57 billion by 2031 | MarketsandMarkets™

May 1, 2026

Popular News

  • Open Networking & Edge Summit Heads to Japan to Advance AI-Native Networking, 6G, and Edge AI Innovation

    0 shares
    Share 0 Tweet 0
  • BURN Launches BUILD, a New Strength Training Concept

    0 shares
    Share 0 Tweet 0
  • PJM Board Names David E. Mills as PJM President and CEO

    0 shares
    Share 0 Tweet 0
  • Lumicell Showcases Expanded Scientific and Clinical Engagement at ASBrS 2026 Annual Meeting

    0 shares
    Share 0 Tweet 0
  • PetMade Formulates Veterinarian-Approved Dog Supplements for Heart Health Featuring CoQ10 and Omega-3s

    0 shares
    Share 0 Tweet 0

About & Contact

  • About Us
  • Branding Style Guide
  • Contact Us
  • Help Centre
  • Media Kit
  • Site Map

Explore Content

  • Events
  • Newsletter
  • Press Releases
  • Topics

Legal & Privacy

  • Advertiser & Partner Policy
  • Communications & Newsletter Policy
  • Contributor Agreement
  • Copyright Policy
  • Privacy Policy
  • Prohibited Content Policy
  • Terms of Service

Tiny Media Brands

  • Silicon Valleys Journal
  • The AI Journal
  • The City Banker
  • The Wall Street Banker
  • World Lifestyler

© 2025 World Lifestyler

No Result
View All Result
  • Home

© 2025 World Lifestyler